Literature DB >> 23773307

Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity.

M Pavkova Goldbergova1, P Nemec, J Lipkova, J Jarkovsky, J Gatterova, D Ambrozkova, A Vasku, M Soucek, N Pavek.   

Abstract

The aim of the study was to examine the relation between polymorphisms and serum levels of selected cytokines (IL-6, IL-13 and IL-15), production of autoantibodies and factors describing rheumatoid arthritis (RA), such as DAS28 and Total Sharp Score. A total of 156 patients with RA according to the ACR criteria, and 200 control subjects were recruited into the study. The measurements of CRP, anti-CCP, the presence of rheumatoid factors (RFs), radiographs of both hands with calculation of Total Sharp Score (TSS) and DAS28 were obtained from all patients with RA. In total, five polymorphisms in genes coding cytokines (IL-6, IL-13 and IL-15) were detected. The levels of these selected cytokines were measured in serum using ELISA method. A significant difference in allele frequencies between patients with RA and controls was observed for IL-15 -267C/T polymorphism. A higher prevalence of heterozygote variants of IL-15 polymorphisms (14035A/T and -267C/T) in the RF IgG- and RF IgA-negative subgroups was observed. Furthermore, the association of polymorphisms in gene for IL-15 with circulating level of IL-15 (14035A/T and 367G/A) and with total RF and Ig-specific RFs (-267C/T) was found. The relation of IL-15 to RFs IgA, IgM, IgG and the measure of DAS28 was proved. The frequency of the T allele of the IL-13 polymorphism -1112C/T was higher in subgroup with faster progression of the disease (TSS/month ≥ 0.1). In conclusion, we present an association of IL-15 gene polymorphisms with the RFs including subtypes (RF, IgG, IgA) underlined by the relation of increased IL-15 levels in circulation to RFs.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23773307     DOI: 10.1111/iji.12065

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  5 in total

1.  The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis.

Authors:  A J Ruiz-Padilla; J I Gamez-Nava; A M Saldaña-Cruz; J D Murillo-Vazquez; M L Vazquez-Villegas; S A Zavaleta-Muñiz; B T Martín-Márquez; J M Ponce-Guarneros; N A Rodriguez Jimenez; A Flores-Chavez; F Sandoval-Garcia; J C Vasquez-Jimenez; E G Cardona-Muñoz; S E Totsuka-Sutto; L Gonzalez-Lopez
Journal:  Biomed Res Int       Date:  2016-09-21       Impact factor: 3.411

Review 2.  Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis.

Authors:  Milena Iwaszko; Sylwia Biały; Katarzyna Bogunia-Kubik
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 3.  Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity.

Authors:  Yasunori Omata; Michael Frech; Taku Saito; Georg Schett; Mario M Zaiss; Sakae Tanaka
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis-A Literature Review.

Authors:  Olga M Koper-Lenkiewicz; Kinga Sutkowska; Natalia Wawrusiewicz-Kurylonek; Ewa Kowalewska; Joanna Matowicka-Karna
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

5.  IL-15 Gene Polymorphism in Celiac Disease Patients and Their Siblings.

Authors:  Yalçın Kara; Makbule Eren; Serap Arslan; Oğuz Çilingir
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.